Ledger.Open graph →
SEC Form D · filed September 25, 2020

Novus Therapeutics, Inc

Offering
$108.1M
Sold
$108.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Irvine, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

John A. Mcbride · Irvine, CADirectorSteven N. Perrin · Irvine, CADirectorGary A. Lyons · Irvine, CADirectorJon N. Kuwahara · Irvine, CAExecKeith A. Katkin · PALO ALTO, CADirectorWalter A. Ogier · Irvine, CADirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · DirectorJohn A. Mcbride · Irvine, CADirectorDavid-Alexandre Gros · Rancho Santa Fe, CAExec · DirectorSteven N. Perrin · Irvine, CADirectorGary A. Lyons · Irvine, CADirectorJon N. Kuwahara · Irvine, CAExecKeith A. Katkin · PALO ALTO, CADirectorWalter A. Ogier · Irvine, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗